ANRis
Operator of a therapeutics platform intended to research, develop, manufacture, and sell drugs for nucleic acid medicine. The company's platform enables the precise targeting of only mutated genes, ov...
Valuation
$0
Share Price
N/A
Total Raised
$1.3M
Last Round
N/A